Indian pharma companies improved credibility in 2016: Nomura
Nomura | December 28, 2016
Indian pharmaceutical companies have signed off 2016 on a positive note and can look forward to improving their performance in the coming year from a quality perspective.The number of warning letters issued by the US Foods and Drug Administration (FDA) declined in 2016 when compared to 2015, according to Nomura analysts Saion Mukherjee and Ayan Deb…